Cyprus announces 2026-2027 vaccination campaign for respiratory viruses

The Cyprus Ministry of Health has officially launched its 2026-2027 vaccination campaign targeting seasonal influenza, COVID-19, and the respiratory syncytial virus (RSV). This initiative aims to protect public health and mitigate the burden on the healthcare system by encouraging timely vaccination throughout the autumn and winter months. All vaccines and necessary medical supplies are provided to the public free of charge.

The initial phase of the influenza vaccination program began in the first ten days of October 2026, focusing on individuals aged 60 and over. For this age group, the Efluelda vaccine is currently being distributed. Personal doctors under the General Health System (GHS) were instructed to submit orders for up to 150 doses between October 6 and October 8. Patients in this category are advised to contact their personal physician directly to arrange an appointment, as they do not need to purchase the vaccine themselves.

While all citizens over six months of age are eligible for the seasonal flu vaccine, priority is strictly given to vulnerable and high-risk groups. The Ministry of Health noted that the Vaxigrip TIV vaccine will also be available for the broader population, with further rollout details expected soon. The administration of vaccines for GHS beneficiaries is handled by personal doctors, while non-beneficiaries and those seeking combined protection should monitor official updates regarding designated vaccination sites.